Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the panic disorders market?

The panic disorders market has experienced steady growth, expected to grow from $10.73 billion in 2024 to $11.19 billion in 2025, at a CAGR of 4.3%. Key factors include the availability of antidepressant medications, rising mental health awareness, increased stress levels, improved mental health services, and advancements in diagnostic criteria.

What will be the panic disorders market size in the future?

The panic disorders market is forecasted to witness strong growth, reaching $13.96 billion in 2029 at a CAGR of 5.7%. Growth will be fueled by emerging pharmacological treatments, increased telepsychiatry adoption, a focus on comorbidities, global mental health initiatives, pharmacogenomics, and public education programs. Key trends include digital mental health interventions, telemedicine-driven treatment, innovations in medications, neurobiological research, and the expansion of wearable technology for remote monitoring.

Get your panic disorders market report here!

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

What main drivers are fueling expansion in the panic disorders market?

The rising cancer incidence is projected to drive the growth of the paclitaxel injection market. Factors such as tobacco and alcohol consumption, along with smoking prevalence, contribute to the increasing number of cancer cases globally. Paclitaxel, a chemotherapy medication, is widely used in the treatment of various cancers, including breast, lung, and ovarian cancer. As cancer rates continue to rise, the demand for paclitaxel as part of chemotherapy regimens will also increase. For instance, in May 2024, the National Cancer Institute estimated that by 2040, global new cancer cases would reach 29.9 million, with 15.3 million cancer-related deaths. Therefore, the growing incidence of cancer is propelling the paclitaxel injection market.

What key areas define the segmentation of the global panic disorders market?

The panic disorders market covered in this report is segmented –

1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder

2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores

Subsegments:

1) By Agoraphobia: Situational Agoraphobia, Non-Situational Agoraphobia

2) By Social Anxiety Disorder (SAD): Performance Anxiety, Generalized Social Anxiety

3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD, Harm OCD, Checking OCD, Symmetry OCD

4) By Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder

5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD, Chronic PTSD, Complex PTSD

6) By Major Depressive Disorder: Recurrent Major Depressive Disorder, Single Episode Major Depressive Disorder

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

Who are the dominant players expanding their reach in the panic disorders market?

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

How are evolving market trends shaping panic disorders Strategies?

Leading firms in the panic disorder market are concentrating on creating advanced solutions like extended-release capsules to maintain their market standing. These capsules gradually release the active components over a predetermined span, usually 12 or 24 hours, providing treatment to conditions that necessitate prolonged medication intake. As an example, Granules India Ltd., an Indian pharmaceutical organization, obtained an abbreviated new drug application (ANDA) authorization from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules in May 2023. This proves bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, produced by Upjohn US 2 LLC. The Venlafaxine HCl extended-release capsules are designed to manage conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They function by enhancing the serotonin and norepinephrine levels in the brain, initiating the dosage generally at 75 mg per day and could be elevated as per the doctor’s discretion.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13191

Which regions are emerging as leaders in the panic disorders market?

North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Basal Cell Carcinoma Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Epidural Abscess Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/epidural-abscess-treatment-global-market-report

Crohn’s Disease (CD) Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: